DK0832241T3 - Streptokoktoksin A-mutanter og anvendelsesfremgangsmåder - Google Patents

Streptokoktoksin A-mutanter og anvendelsesfremgangsmåder

Info

Publication number
DK0832241T3
DK0832241T3 DK96921589T DK96921589T DK0832241T3 DK 0832241 T3 DK0832241 T3 DK 0832241T3 DK 96921589 T DK96921589 T DK 96921589T DK 96921589 T DK96921589 T DK 96921589T DK 0832241 T3 DK0832241 T3 DK 0832241T3
Authority
DK
Denmark
Prior art keywords
spe
toxin
methods
vaccine
mutants
Prior art date
Application number
DK96921589T
Other languages
English (en)
Inventor
Patrick M Schlievert
Manuela Roggiani
Jennifer Stoehr
Douglas Ohlendorf
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Application granted granted Critical
Publication of DK0832241T3 publication Critical patent/DK0832241T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96921589T 1995-06-07 1996-06-07 Streptokoktoksin A-mutanter og anvendelsesfremgangsmåder DK0832241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48026195A 1995-06-07 1995-06-07
PCT/US1996/010252 WO1996040930A1 (en) 1995-06-07 1996-06-07 Mutants of streptococcal toxin a and methods of use

Publications (1)

Publication Number Publication Date
DK0832241T3 true DK0832241T3 (da) 2005-08-01

Family

ID=23907283

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96921589T DK0832241T3 (da) 1995-06-07 1996-06-07 Streptokoktoksin A-mutanter og anvendelsesfremgangsmåder

Country Status (12)

Country Link
US (3) US6632441B2 (da)
EP (2) EP1538208A3 (da)
JP (1) JPH11514844A (da)
KR (1) KR100456594B1 (da)
AT (1) ATE291625T1 (da)
AU (1) AU723116B2 (da)
CA (1) CA2221480A1 (da)
DE (1) DE69634510T2 (da)
DK (1) DK0832241T3 (da)
ES (1) ES2239332T3 (da)
PT (1) PT832241E (da)
WO (1) WO1996040930A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517061B (en) * 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
BR9713679A (pt) 1996-12-06 2001-07-17 Univ Minnesota Mutantes de toxina c de estreptococo e métodos de uso
US6774218B2 (en) 1996-12-06 2004-08-10 Regents Of The University Of Minnesota Mutants of streptococcal toxin C and methods of use
BR9714641A (pt) * 1996-12-06 2002-01-22 Univ Minnesota Mutantes de toxina a de estreptococo e métodos de uso
US6075119A (en) * 1997-04-07 2000-06-13 The Rockefeller University Peptides useful for reducing symptoms of toxic shock syndrome
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
US6872394B1 (en) 1997-12-02 2005-03-29 Idaho Research Foundation, Inc. Non-toxic immune stimulating enterotoxin compositions
EP1127132A1 (en) * 1998-10-07 2001-08-29 The Rockefeller University Peptides useful for reducing symptoms of toxic shock syndrome and septic shock
WO2002083169A1 (en) * 2001-04-13 2002-10-24 Idaho Research Foundation, Inc. Modified staphylococcal enterotoxins and expression systems therefore
SE0102327D0 (sv) * 2001-06-28 2001-06-28 Active Biotech Ab A novel engineered superantigen for human therapy
US20070178113A1 (en) * 2005-11-22 2007-08-02 Backstrom B T Superantigen conjugate
AU2008287286B2 (en) 2007-04-13 2013-10-10 The Board Of Regents Of The University Of Oklahoma Mutants of cholesterol-dependent cytolysins and uses thereof
RU2380316C1 (ru) * 2008-10-13 2010-01-27 Закрытое акционерное общество "Макполимер" Способ получения органоглины
MX2016017136A (es) 2014-06-27 2017-05-10 Abbott Lab Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2).
ES2993430T3 (en) 2014-11-21 2024-12-30 Univ Oklahoma Pneumolysin mutants and methods of use thereof
EP3411409B1 (en) 2016-01-10 2025-10-08 Neotx Therapeutics Ltd. Anti pd-1/anti-pd-l1 antibodies for enhancing the potency of superantigen mediated cancer immunotherapy
AU2020275142A1 (en) 2019-05-15 2021-12-16 Neotx Therapeutics Ltd. Cancer treatment
JP2023517011A (ja) 2020-03-05 2023-04-21 ネオティーエックス セラピューティクス リミテッド 免疫細胞を用いて癌を治療するための方法および組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784948A (en) * 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
US5336598A (en) 1989-11-15 1994-08-09 National Jewish Center For Immunology And Respiratory Medicine Method for diagnosing a superantigen caused pathologial condition via assay of T-cells
US5298396A (en) 1989-11-15 1994-03-29 National Jewish Center For Immunology And Respiratory Medicine Method for identifying T cells disease involved in autoimmune disease
CA2128415A1 (en) 1992-01-28 1993-08-05 John W. Kappler Protective effects of mutated superantigens

Also Published As

Publication number Publication date
ATE291625T1 (de) 2005-04-15
US6632441B2 (en) 2003-10-14
EP0832241A1 (en) 1998-04-01
CA2221480A1 (en) 1996-12-19
US6870042B1 (en) 2005-03-22
EP1538208A3 (en) 2007-05-23
DE69634510T2 (de) 2006-01-26
KR19990022750A (ko) 1999-03-25
EP0832241B1 (en) 2005-03-23
US20060039925A1 (en) 2006-02-23
US20020054887A1 (en) 2002-05-09
ES2239332T3 (es) 2005-09-16
AU6278296A (en) 1996-12-30
WO1996040930A1 (en) 1996-12-19
AU723116B2 (en) 2000-08-17
PT832241E (pt) 2005-08-31
JPH11514844A (ja) 1999-12-21
DE69634510D1 (de) 2005-04-28
KR100456594B1 (ko) 2005-06-17
EP1538208A2 (en) 2005-06-08

Similar Documents

Publication Publication Date Title
PT832241E (pt) Mutantes de toxina a estreptococica e metodos de utilizacao
ATE314475T1 (de) Rekombinantes pseudomonas exotoxin mit gesteigerter aktivität
EA200100565A1 (ru) Новые стрептококковые антигены
WO2002040506A3 (en) Modified clostridial neurotoxins with altered biological persistence
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
DK0732937T4 (da) Ikke-toxisk slimhindeadjuvans
ES2081370T3 (es) Gen y proteina de bacillus thuringiensis, y su utilizacion.
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
HUP9900768A2 (hu) Photorhabdusból származó inszekticid protein toxinok
NO962560L (no) Materialer og metoder ved påvisning av stpahylococcus aureus
PT946730E (pt) Mutantes de toxina estreptococica c e metodos de utilizacao
PT866720E (pt) Proteina ob para aumentar a massa do tecido mole
FI943389L (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
WO1998024911A3 (en) Mutants of streptococcal toxin a and methods of use
ATE220688T1 (de) Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
EA200100700A1 (ru) Гены и белки и их применение
ATE383425T1 (de) Virulenzgene und deren proteine und verwendungen
RU93031380A (ru) Биологический инсектицид для борьбы с чешуекрылыми насекомыми
DE69531731D1 (de) Neue pestizid-zusammenstellungen und bacillus thuringiensis stämme
DK0647654T3 (da) Anomere fluor-ribosylaminer
BR0007255A (pt) Derivados carbamato de diaril 1,3,4-oxadiazolona
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
AU1720497A (en) Use of primers for universal fingerprint analysis